Market Cap (In HKD)
720.9 Million
Revenue (In HKD)
18.75 Million
Net Income (In HKD)
-385.03 Million
Avg. Volume
188.23 Thousand
- Currency
- HKD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.28-4.0
- PE
- -
- EPS
- -
- Beta Value
- 0.97
- ISIN
- KYG989M51017
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Xiaoyi Li Ph.D.
- Employee Count
- -
- Website
- https://www.zkoph.com
- Ipo Date
- 2021-04-29
- Details
- Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China.
More Stocks
-
2455
-
HSCL
-
SIMPLXREASimplex Realty Limited
SIMPLXREA
-
5981
-
SHIVAGRShivagrico Implements Limited
SHIVAGR
-
HAR
-
PATPATRIZIA SE
PAT
-
GROCGreenRoc Mining plc
GROC